Delivering the Depth and Detail Neurology Deserves

Delivering-depth-detail-neurology-deserves

Neurology therapies face some of the greatest hurdles to early diagnosis, access, and adoption. This infographic highlights how NorstellaLinQ captures what others miss—unlocking the full complexity of the patient journey so you can drive faster diagnosis, generate stronger evidence, position therapies more effectively, and deliver better outcomes for patients who need them most. Download the […]

Introducing Trigger Alerts

closer-patient-NorstellaLinQ-EMR-data

Claims data can’t tell you what’s actually happening with your patients—not why treatment changed, what the latest labs revealed, or whether a physician is considering switching therapies. This infographic explores how Trigger Alerts powered by NorstellaLinQ bring you closer to the patient, earlier in their journey, with the clarity your brand and sales teams need […]

Get Closer to the Patient Than Ever Before with NorstellaLinQ EHR Data

closer-patient-NorstellaLinQ-EMR-data

If you’re only using claims and national reference lab data, you’re overlooking critical insights—like specialty pharmacy fills, treatment modifications, and physician rationale—that reveal the real drivers behind prescribing behavior. This infographic explores how NorstellaLinQ EHR fills these gaps with structured and unstructured clinical data that helps you see more, understand faster, and act smarter. What’s […]

Targeting Patients and Fueling Brand Strategy with Trigger Alerts

targeting-patients-fueling-brand-strategy

Discover how AI-powered Trigger Alerts and integrated real-world data helped identify high-risk patients, equip field teams with timely clinical insights, and strengthen brand engagement strategies. Identified high-risk patients with AI-powered Trigger Alerts Delivered timely clinical insights to field teams Strengthened brand strategy with integrated real-world data

Global Pharmaceutical Company Leverages IHD Analytics Platform to Train and Educate Employees on Real-World Data Analytics and AI/ML Methodology

train-educate-employees-real-world-data-analytics-ai-ml-methodology

See how an internal datathon helped a global pharmaceutical company strengthen real-world data capabilities, foster cross-functional collaboration, and accelerate healthcare analytics innovation to: Build real-world data and AI/ML expertise across teams Accelerate analytics with an intuitive self-service platform Reduce reliance on external vendors for faster insights

Uncovering New Rare Disease Patients Using Structured and Unstructured Real-World Data

uncovering-new-rare-disease-patients

Learn how integrated structured and unstructured real-world data helped identify rare disease patients, quantify the addressable population, and strengthen commercial and payer strategies ahead of launch. Identified hidden rare disease patients with integrated real-world data Quantified the addressable patient population with confidence Strengthened launch and payer strategies with actionable insights

Breaking Barriers in Rare Disease Drug Development

Breaking-barriers-rare-disease-drug-development

Bringing rare disease treatments from pipeline to patient Rare diseases affect more than 395 million people worldwide, yet only 5% have an FDA-approved treatment. The challenges of small patient populations, regulatory complexities, and limited clinical data have historically slowed progress. But the landscape is changing. This infographic explores the key barriers in rare disease drug […]

Unstructured EHR Data Expands Cohort Identification by 1,500%

unstructured-ehr-data-expands

When a biopharma manufacturer began developing a new therapy to treat a rare disease, its leadership team realized that finding diagnosed patients would be a challenge. The company wanted to conduct feasibility research on the indication to map the patient journey, identify patients with a specific subtype, and quantify the patient population that would potentially […]

Powering Unbiased Outcomes Research with Longitudinal Data

powering-unbiased-outcomes-research-longitudinal-data

In preparation for a new launch, a medical device company needed to conduct a health economics and outcomes research (HEOR) study on cemented and uncemented knee arthroplasties. The company wanted to know if readmission and infection rates differed for arthroplasty patients depending on the fixation method used. By conducting this research, the company hoped to […]

Complex Cohort Identification Fuels Real-Time HCP Targeting

complex-cohort-identification-fuels-real-time-hcp-targeting

A large manufacturer preparing for the launch of its new oncology therapy sought a deeper understanding of the specific disease state. The company’s market access team wanted to track specialist referral patterns and determine the average time between diagnosis and treatment. The manufacturer also needed to identify patients who were potentially eligible for its product, […]

Norstella Brands